362 related articles for article (PubMed ID: 24029417)
41. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
42. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
[TBL] [Abstract][Full Text] [Related]
43. Curcuma wenyujin extract induces apoptosis and inhibits proliferation of human cervical cancer cells in vitro and in vivo.
Lim CB; Ky N; Ng HM; Hamza MS; Zhao Y
Integr Cancer Ther; 2010 Mar; 9(1):36-49. PubMed ID: 20150221
[TBL] [Abstract][Full Text] [Related]
44. Ethyl 2- [N-m-chlorobenzyl- (2'-methyl)] anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOT01006) induces apoptosis in human cervical cancer HeLa cells.
Huang AC; Lin TP; Weng YS; Ho YT; Lin HJ; Huang LJ; Kuo SC; Chung JG
Anticancer Res; 2007; 27(4B):2505-14. PubMed ID: 17695546
[TBL] [Abstract][Full Text] [Related]
45. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.
Wang W; Sun Y; Li X; Li H; Chen Y; Tian Y; Yi J; Wang J
Oncol Rep; 2011 Nov; 26(5):1143-8. PubMed ID: 21769433
[TBL] [Abstract][Full Text] [Related]
46. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
[No Abstract] [Full Text] [Related]
47. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
[TBL] [Abstract][Full Text] [Related]
48. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
Zhang Y; Shen X
Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
[TBL] [Abstract][Full Text] [Related]
49. Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.
Dai Q; Ling YH; Lia M; Zou YY; Kroog G; Iwata KK; Perez-Soler R
Clin Cancer Res; 2005 Feb; 11(4):1572-8. PubMed ID: 15746062
[TBL] [Abstract][Full Text] [Related]
50. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
51. Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer.
Nawrocki ST; Kelly KR; Smith PG; Espitia CM; Possemato A; Beausoleil SA; Milhollen M; Blakemore S; Thomas M; Berger A; Carew JS
Clin Cancer Res; 2013 Jul; 19(13):3577-90. PubMed ID: 23633453
[TBL] [Abstract][Full Text] [Related]
52. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
53. [Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells].
Liu SS; Lu D; Miao LF; Xiong QY; Chen XP; Wang Y; Guo F
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):609-13. PubMed ID: 21029618
[TBL] [Abstract][Full Text] [Related]
54. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
Hantel C; Jung S; Mussack T; Reincke M; Beuschlein F
Endocr Relat Cancer; 2014 Jun; 21(3):383-94. PubMed ID: 24532475
[TBL] [Abstract][Full Text] [Related]
55. hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.
Nakamura M; Kyo S; Kanaya T; Yatabe N; Maida Y; Tanaka M; Ishida Y; Fujii C; Kondo T; Inoue M; Mukaida N
Cancer Gene Ther; 2004 Jan; 11(1):1-7. PubMed ID: 14681721
[TBL] [Abstract][Full Text] [Related]
56. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
57. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
58. Amygdalin induces apoptosis in human cervical cancer cell line HeLa cells.
Chen Y; Ma J; Wang F; Hu J; Cui A; Wei C; Yang Q; Li F
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):43-51. PubMed ID: 23137229
[TBL] [Abstract][Full Text] [Related]
59. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
60. GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling.
Parida S; Pal I; Parekh A; Thakur B; Bharti R; Das S; Mandal M
Cell Death Dis; 2016 Mar; 7(3):e2154. PubMed ID: 27010855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
